210 related articles for article (PubMed ID: 18725193)
1. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.
Zheng L; Li B; Qian W; Zhao L; Cao Z; Shi S; Gao J; Zhang D; Hou S; Dai J; Wang H; Guo Y
Biochem Biophys Res Commun; 2008 Oct; 375(4):619-22. PubMed ID: 18725193
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a novel anti-IgE monoclonal antibody.
Qian W; Zhang X; Li B; Zhang D; Tong Q; Chen L; Zheng L; Kou G; Wang H; Hou S; Guo Y
Biochem Biophys Res Commun; 2010 May; 395(4):547-52. PubMed ID: 20394728
[TBL] [Abstract][Full Text] [Related]
3. Epitope-specific antibody response to IgE by mimotope immunization.
Rudolf MP; Vogel M; Kricek F; Ruf C; Zürcher AW; Reuschel R; Auer M; Miescher S; Stadler BM
J Immunol; 1998 Apr; 160(7):3315-21. PubMed ID: 9531289
[TBL] [Abstract][Full Text] [Related]
4. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
5. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
6. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
[TBL] [Abstract][Full Text] [Related]
7. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.
Hamilton RG; Marcotte GV; Saini SS
J Immunol Methods; 2005 Aug; 303(1-2):81-91. PubMed ID: 16045925
[TBL] [Abstract][Full Text] [Related]
8. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
Nowak D
Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody.
Scheinfeld N
Dermatol Online J; 2005 Mar; 11(1):2. PubMed ID: 15748543
[TBL] [Abstract][Full Text] [Related]
10. Thermal sensitivity and flexibility of the Cε3 domains in immunoglobulin E.
Doré KA; Davies AM; Drinkwater N; Beavil AJ; McDonnell JM; Sutton BJ
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1336-1347. PubMed ID: 28844738
[TBL] [Abstract][Full Text] [Related]
11. Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha.
Garman SC; Wurzburg BA; Tarchevskaya SS; Kinet JP; Jardetzky TS
Nature; 2000 Jul; 406(6793):259-66. PubMed ID: 10917520
[TBL] [Abstract][Full Text] [Related]
12. Structure of the omalizumab Fab.
Jensen RK; Plum M; Tjerrild L; Jakob T; Spillner E; Andersen GR
Acta Crystallogr F Struct Biol Commun; 2015 Apr; 71(Pt 4):419-26. PubMed ID: 25849503
[TBL] [Abstract][Full Text] [Related]
13. Identification of peptides that bind to the constant region of a humanized IgG1 monoclonal antibody using phage display.
Ehrlich GK; Bailon P
J Mol Recognit; 1998; 11(1-6):121-5. PubMed ID: 10076823
[TBL] [Abstract][Full Text] [Related]
14. Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab.
Davies AM; Allan EG; Keeble AH; Delgado J; Cossins BP; Mitropoulou AN; Pang MOY; Ceska T; Beavil AJ; Craggs G; Westwood M; Henry AJ; McDonnell JM; Sutton BJ
J Biol Chem; 2017 Jun; 292(24):9975-9987. PubMed ID: 28438838
[TBL] [Abstract][Full Text] [Related]
15. Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library.
Hantusch B; Krieger S; Untersmayr E; Schöll I; Knittelfelder R; Flicker S; Spitzauer S; Valenta R; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E
J Allergy Clin Immunol; 2004 Dec; 114(6):1294-300. PubMed ID: 15577826
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab decreases nonspecific airway hyperresponsiveness in vitro.
Berger P; Scotto-Gomez E; Molimard M; Marthan R; Le Gros V; Tunon-de-Lara JM
Allergy; 2007 Feb; 62(2):154-61. PubMed ID: 17298424
[TBL] [Abstract][Full Text] [Related]
17. Cyclic peptides selected by phage display mimic the natural epitope recognized by a monoclonal anti-colicin A antibody.
Coulon S; Metais JY; Chartier M; Briand JP; Baty D
J Pept Sci; 2004 Nov; 10(11):648-58. PubMed ID: 15568679
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.
Pennington LF; Tarchevskaya S; Brigger D; Sathiyamoorthy K; Graham MT; Nadeau KC; Eggel A; Jardetzky TS
Nat Commun; 2016 May; 7():11610. PubMed ID: 27194387
[TBL] [Abstract][Full Text] [Related]
19. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.
Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M
Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab in the treatment of severe asthma: efficacy and current problems.
Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
